ADVANCED ENZYME TECHNOLOGIES LTD.

NSE : ADVENZYMESBSE : 540025ISIN CODE : INE837H01020Industry : Pharmaceuticals & DrugsHouse : Private
BSE385.40-0.85 (-0.22 %)
PREV CLOSE ( ) 386.25
OPEN PRICE ( ) 386.20
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 19384
TODAY'S LOW / HIGH ( )384.15 393.20
52 WK LOW / HIGH ( )252.05 425.1
NSE386.300.85 (+0.22 %)
PREV CLOSE( ) 385.45
OPEN PRICE ( ) 386.85
BID PRICE (QTY) 386.30 (1)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 97998
TODAY'S LOW / HIGH( ) 384.30 393.55
52 WK LOW / HIGH ( )253.4 425.15

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.